These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
570 related articles for article (PubMed ID: 14505137)
1. A severe hepatitis flare in an HBV-HCV coinfected patient during combination therapy with alpha-interferon and ribavirin. Yalcin K; Degertekin H; Yildiz F; Kilinc N J Gastroenterol; 2003; 38(8):796-800. PubMed ID: 14505137 [TBL] [Abstract][Full Text] [Related]
2. Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy. Chuang WL; Dai CY; Chang WY; Lee LP; Lin ZY; Chen SC; Hsieh MY; Wang LY; Yu ML Antivir Ther; 2005; 10(1):125-33. PubMed ID: 15751770 [TBL] [Abstract][Full Text] [Related]
3. Chronic hepatitis C virus infection in renal transplant: treatment and outcome. Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715 [TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus-RNA clearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin. Soriano V; Núñez M; Camino N; Maida I; Barreiro P; Romero M; Martin-Carbonero L; Garcia-Samaniego J; González-Lahoz J Antivir Ther; 2004 Aug; 9(4):505-9. PubMed ID: 15456081 [TBL] [Abstract][Full Text] [Related]
5. High doses of alpha-interferon are required in chronic hepatitis due to coinfection with hepatitis B virus and hepatitis C virus: long term results of a prospective randomized trial. Villa E; Grottola A; Buttafoco P; Colantoni A; Bagni A; Ferretti I; Cremonini C; Bertani H; Manenti F Am J Gastroenterol; 2001 Oct; 96(10):2973-7. PubMed ID: 11693335 [TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus-specific T-cell proliferation and cytokine secretion in chronic hepatitis B e antibody-positive patients treated with ribavirin and interferon alpha. Rico MA; Quiroga JA; Subirá D; Castañón S; Esteban JM; Pardo M; Carreño V Hepatology; 2001 Jan; 33(1):295-300. PubMed ID: 11124848 [TBL] [Abstract][Full Text] [Related]
8. Treatment of chronic hepatitis B virus infection - Dutch national guidelines. Buster EH; van Erpecum KJ; Schalm SW; Zaaijer HL; Brouwer JT; Gelderblom HC; de Knegt RJ; Minke Bakker C; Reesink HW; Janssen HL; Neth J Med; 2008; 66(7):292-306. PubMed ID: 18663260 [TBL] [Abstract][Full Text] [Related]
9. Individualization of interferon therapy using serum hepatitis B virus DNA to reduce viral relapse in patients with chronic hepatitis B: a randomized controlled trial. Chung YH; Song BC; Lee GC; Shin JW; Ryu SH; Jung SA; Yoo K; Lee HC; Lee YS; Suh DJ Eur J Gastroenterol Hepatol; 2003 May; 15(5):489-93. PubMed ID: 12702905 [TBL] [Abstract][Full Text] [Related]
10. [Monitoring patients with chronic hepatitis during and after therapy]. Colić-Cvrlje V; Mise S Acta Med Croatica; 2009 Dec; 63(5):377-83. PubMed ID: 20198895 [TBL] [Abstract][Full Text] [Related]
11. Natural leukocyte interferon alfa for the treatment of chronic viral hepatitis in heart transplant recipients. Fagiuoli S; Pevere S; Minniti F; Livi U; Caforio AL; Naccarato R; Chiaramonte M Transplantation; 2003 Apr; 75(7):982-6. PubMed ID: 12698084 [TBL] [Abstract][Full Text] [Related]
12. Chronic hepatitis C responds poorly to combination therapy in chronic hepatis B carriers. Senturk H; Tahan V; Canbakan B; Uraz S; Ulger Y; Ozaras R; Tabak F; Mert A; Ozbay G Neth J Med; 2008 May; 66(5):191-5. PubMed ID: 18490796 [TBL] [Abstract][Full Text] [Related]
13. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults. Rockstroh JK; Bhagani S; Benhamou Y; Bruno R; Mauss S; Peters L; Puoti M; Soriano V; Tural C; HIV Med; 2008 Feb; 9(2):82-8. PubMed ID: 18257771 [TBL] [Abstract][Full Text] [Related]
14. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C. Abdelmalek MF; Firpi RJ; Soldevila-Pico C; Reed AI; Hemming AW; Liu C; Crawford JM; Davis GL; Nelson DR Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857 [TBL] [Abstract][Full Text] [Related]
15. Management of patients co-infected with HBV and HCV. Coffin CS; Terrault NA Expert Rev Anti Infect Ther; 2009 Jun; 7(5):549-58. PubMed ID: 19485795 [TBL] [Abstract][Full Text] [Related]
16. Sequential changes of hepatitis C virus antibody profiles during treatment of chronic hepatitis C of genotype 1b: pretreatment antibody response to E2/NS1 correlated sustained response. Chu CM; Sheen IS; Liaw YF Infection; 2004 Jun; 32(3):153-6. PubMed ID: 15188075 [TBL] [Abstract][Full Text] [Related]
17. Advances in the treatment of hepatitis C. Lawrence SP Adv Intern Med; 2000; 45():65-105. PubMed ID: 10635046 [TBL] [Abstract][Full Text] [Related]
18. Presence of hepatitis C virus (HCV)-RNA in peripheral blood mononuclear cells in HCV serum negative patients during interferon and ribavirin therapy. Januszkiewicz-Lewandowska D; Wysocki J; Pernak M; Nowicka K; Zawada M; Rembowska J; Lewandowski K; Mańkowski P; Nowak J Jpn J Infect Dis; 2007 Feb; 60(1):29-32. PubMed ID: 17314422 [TBL] [Abstract][Full Text] [Related]
19. Co-infection with hepatitis B does not alter treatment response in chronic hepatitis C. Uyanikoglu A; Akyuz F; Baran B; Simsek BP; Ermis F; Demir K; Gulluoglu M; Badur S; Kaymakoglu S Clin Res Hepatol Gastroenterol; 2013 Nov; 37(5):485-90. PubMed ID: 23665172 [TBL] [Abstract][Full Text] [Related]
20. [Monitoring patients with chronic hepatitis during and after therapy]. Colić-Cvrlje V Acta Med Croatica; 2005; 59(5):413-7. PubMed ID: 16381236 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]